Terumo BCT Executive and Leadership Team

Antoinette Gawin, the President & Chief Executive Officer at Terumo BCT, directs the company's overarching strategy and global operations. Gawin steers the organization's mission to develop and supply critical blood components and cellular technologies, ensuring alignment with market needs and advancements in healthcare. Overseeing all business units, Gawin drives innovation in apheresis collections, therapeutic apheresis, cell therapy systems, whole blood processing, and pathogen reduction technologies. This leadership role involves fostering strategic partnerships and guiding the company's expansion into new markets, thereby enhancing its impact on patient care worldwide. Antoinette Gawin's vision ensures Terumo BCT remains at the forefront of medical technology, delivering solutions that improve lives.

Russell Spinney, the Chief Financial Officer at Terumo BCT, manages the company's financial health and strategic fiscal planning. Spinney oversees all financial operations, including budgeting, forecasting, and resource allocation, ensuring robust financial performance across global operations. This executive directs the financial strategies that support Terumo BCT's development and supply of blood components and cellular technologies, including apheresis collections and cell therapy systems. By optimizing financial processes and managing investment, Russell Spinney ensures the company's sustained growth and profitability. The Chief Financial Officer's oversight extends to risk management and compliance, safeguarding the company's assets and supporting its mission to advance healthcare solutions.

Stuart Bedell, the Division Chief Financial Officer, Plasma Innovations Business Unit at Terumo BCT, leads financial strategy specifically for the Plasma Innovations segment. Bedell directs the fiscal operations and financial planning for this critical business unit, ensuring its profitability and strategic alignment with Terumo BCT's broader objectives. This role involves detailed financial analysis, investment oversight, and resource management tailored to the unique demands of plasma-derived therapies and related technologies. Stuart Bedell's expertise supports the innovation and expansion of plasma-based solutions, contributing directly to the company's market leadership. The Division Chief Financial Officer's focus ensures efficient capital deployment and financial integrity within the Plasma Innovations Business Unit.

Bon Lopez, the Senior Vice President, Global Human Resources (Chief People Officer) at Terumo BCT, architects the company's global human capital strategy. Lopez oversees all aspects of talent management, organizational development, and employee engagement, fostering a culture that supports innovation in blood components and cellular technologies. This leadership position drives initiatives to attract, retain, and develop a high-performing workforce across Terumo BCT's international operations. Bon Lopez ensures that human resources policies and practices align with the company's mission to advance healthcare solutions through apheresis collections and cell therapy systems. The Chief People Officer's focus on employee well-being and professional growth is integral to Terumo BCT's sustained success and market impact.